Twist Bioscience Announces Proposed Public Offering of Common Stock

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it intends to offer and sell in an underwritten public offering up to $250 million of shares of its common stock and certain selling stockholders intend to offer 75,000 shares in the offering.